| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/25/2001 | WO2000066587A3 Polyamines and their use in therapy |
| 01/25/2001 | WO2000065034A3 Pseudotyped retroviral vector for gene therapy of cancer |
| 01/25/2001 | WO2000061174A3 Use of pegylated interferon alpha for renal cell carcinoma treatment |
| 01/25/2001 | WO2000061156A3 Methods of treating schizophrenia |
| 01/25/2001 | DE19934610A1 Rapid-release extrudates containing low viscosity hydroxypropylcellulose, useful for formulating plant protecting agents and oral pharmaceutical and veterinary compositions |
| 01/25/2001 | DE19934523A1 Transdermalsysteme zur Abgabe von Muscarin-Rezeptor-Antagonisten und ihre Verwendung zur Behandlung von Spasmen der glatten Muskulatur im urologischen Bereich Transdermal systems for the delivery of muscarinic receptor antagonists and their use for treating spasm of smooth muscle in the urological field |
| 01/25/2001 | DE19933719A1 Strukturprotein in Adeno-assoziiertem Virus mit veränderten chromatographischen Eigenschaften, seine Herstellung und Verwendung Structural protein in adeno-associated virus with altered the chromatographic properties, its preparation and use |
| 01/25/2001 | DE19933148A1 Ambroxolhaltige Lutschtablette Ambroxol lozenge |
| 01/25/2001 | DE19932603A1 Wirkstoffhaltiger Mehrschichtfilm aus in situ vernetzten hydrophilen Polymeren Medicated multilayer film composed of crosslinked hydrophilic polymers in situ |
| 01/25/2001 | CA2379366A1 A liposome composition having resistance to freeze/thaw damage |
| 01/25/2001 | CA2379354A1 Formulations for il-115 |
| 01/25/2001 | CA2379060A1 Neutral lipopolymer and liposomal compositions containing same |
| 01/25/2001 | CA2378946A1 Psca: prostate stem cell antigen and uses thereof |
| 01/25/2001 | CA2378829A1 Sustained release drug dispersion delivery device |
| 01/25/2001 | CA2378714A1 Sustained release compositions, methods for producing the same and uses thereof |
| 01/25/2001 | CA2378430A1 Methods and apparatus for preparation of lipid vesicles |
| 01/25/2001 | CA2378336A1 Rapid immediate release oral dosage form |
| 01/25/2001 | CA2340721A1 Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor |
| 01/24/2001 | EP1070741A1 Coprocessed polysaccharide product with crosslinked polyvinylpyrrolidone |
| 01/24/2001 | EP1070740A1 Coprocessed polysaccharide product with insoluble carboxymethylcellulose |
| 01/24/2001 | EP1070502A2 Compositions and methods for treating or preventing inflammatory diseases |
| 01/24/2001 | EP1070501A1 Method of preparing a dispersible fluoxetine tablet |
| 01/24/2001 | EP1070085A1 DUAL A v?b 3? AND METASTASIS-ASSOCIATED RECEPTOR LIGANDS |
| 01/24/2001 | EP1070047A2 Lipids |
| 01/24/2001 | EP1069919A2 Stimulus sensitive gel with radioisotope and methods of making |
| 01/24/2001 | EP1069916A2 Latent reactive blood compatible agents |
| 01/24/2001 | EP1069915A2 Hydroxylation activated drug release |
| 01/24/2001 | EP1069914A1 Controlled release tablet produced from linear water-insoluble polysaccharides |
| 01/24/2001 | EP1069913A1 Gelling ophthalmic compositions containing xanthan gum |
| 01/24/2001 | EP1069912A1 Injectable igf-formulations containing succinate as buffering agent |
| 01/24/2001 | EP1069911A1 A novel nitroreductase and therapeutic uses therefor |
| 01/24/2001 | EP1069910A1 Adjuvant compositions |
| 01/24/2001 | EP1069898A1 Topical antiseptic compositions and methods |
| 01/24/2001 | EP1069892A1 Therapeutic system which can be moisture-activated |
| 01/24/2001 | EP1069891A1 Wettable microcapsules having ethylcellulose coated cores |
| 01/24/2001 | EP1069890A1 Incorporation of active substances in carrier matrixes |
| 01/24/2001 | EP1069889A1 Partikulärer wirkstoffträger für die pulmonale applikation |
| 01/24/2001 | EP1069886A1 Topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, with a prolonged effect of an incorporated active substance |
| 01/24/2001 | EP1069885A1 Ophthalmic solution comprising glycogen |
| 01/24/2001 | EP0868192A4 Fast drying, film forming iodine release solution |
| 01/24/2001 | EP0712389B1 Therapeutic compound - fatty acid conjugates |
| 01/24/2001 | EP0630260B1 Polysaccharide-protein conjugates |
| 01/24/2001 | CN1281373A Pharmaceutical compositions containing cyclodextrins and taxoids |
| 01/24/2001 | CN1281372A Pharmaceutical Hydrogel formulations, drug delivery devices and methods |
| 01/24/2001 | CN1281370A Stabilized teriparatide solutions |
| 01/24/2001 | CN1281366A Prevention and treatment of amyloidogenic disease |
| 01/24/2001 | CN1281355A Biodegradable mixed polymeric micelles for gene delivery |
| 01/24/2001 | CN1281032A Process for back extraction of medicinal plant oil with supercritical CO2 |
| 01/24/2001 | CN1280818A Application of ring enamine as light stability agent |
| 01/23/2001 | US6177561 Preparation of acid amides and metallization of compounds |
| 01/23/2001 | US6177554 Nucleic acid transporter systems |
| 01/23/2001 | US6177549 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof |
| 01/23/2001 | US6177477 Sterile oil in water emulsion for parenteral administration; mixture containing tromethamine |
| 01/23/2001 | US6177436 Administering with viricide; side effect reduction |
| 01/23/2001 | US6177414 Polymaminoamide dendrimer star polymer carrying salicylic acid moieties; drug delivery |
| 01/23/2001 | US6177413 Dissolving salicylic acid and acetylsalicylic acid in aqueous potassium hydroxide, drying, mixing the salt with a liquid carrier |
| 01/23/2001 | US6177404 Administering a conjugate of given classes of cytotoxic agent and an oligopeptide which is a sequence of amino acids that is selectively proteolytically cleaved by free prostate specific antigen |
| 01/23/2001 | US6177274 Expression vector for transfering nucleotide sequences to liver cells; for the amplified efficiency of transformation and transfection of preferential cells |
| 01/23/2001 | US6177253 Screening methods for the identification of anti-HIV compounds employing a cyclosporine-specific monoclonal antibody that cross-reacts with HIV-1 p24 |
| 01/23/2001 | US6177103 Processes to generate submicron particles of water-insoluble compounds |
| 01/23/2001 | US6177101 Delavirdine high strength tablet formulation |
| 01/23/2001 | US6177096 Water soluble film for oral administration with instant wettability |
| 01/23/2001 | US6177092 Self-foaming cleansing systems |
| 01/23/2001 | US6177090 Topical composition containing a silicone-grafted polymer and an amine silicone and/or a silicone gum or resin |
| 01/23/2001 | US6177087 Administering a polymer conjugate |
| 01/23/2001 | US6177079 Monoclonal antibodies against interleukins |
| 01/23/2001 | US6177074 Polyethylene glycol modified interferon therapy |
| 01/23/2001 | US6177059 Drugs and complexes with lipids |
| 01/23/2001 | CA2296884C Targeted liposomes and methods for liposome-protein coupling |
| 01/20/2001 | WO2001005376A1 New pharmaceutical formulation |
| 01/20/2001 | CA2328102A1 New pharmaceutical formulation |
| 01/18/2001 | WO2001004207A1 Preparations containing no cross-linking agents |
| 01/18/2001 | WO2001004195A1 Film coatings and film coating compositions based on polyvinyl alcohol |
| 01/18/2001 | WO2001004187A1 Preparations that are devoid of cross-linking agents |
| 01/18/2001 | WO2001004160A1 Anti-idiotypic antibodies of fibroblast growth factors and their use as medicines |
| 01/18/2001 | WO2001004156A1 Peptides that lower blood glucose levels |
| 01/18/2001 | WO2001004135A2 Crosslinked dna condensate compositions and gene delivery methods |
| 01/18/2001 | WO2001003917A2 Multilayered film containing an active substance and made of cross-linked hydrophilic polymers |
| 01/18/2001 | WO2001003821A1 Method of particle formation |
| 01/18/2001 | WO2001003774A2 Pharmaceutical composition for the treatment of calcification |
| 01/18/2001 | WO2001003742A1 Drug composition for topical administration |
| 01/18/2001 | WO2001003741A1 Growth hormone formulations |
| 01/18/2001 | WO2001003738A1 Polymer-type agents for preventing metastasis and recurrence of cancer and method for preventing metastasis and recurrence |
| 01/18/2001 | WO2001003735A1 Cancer treatment using angiopoietins targeted to aminophospholipids |
| 01/18/2001 | WO2001003726A1 Stable factor viii compositions |
| 01/18/2001 | WO2001003723A1 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 01/18/2001 | WO2001003698A1 Taste masked pharmaceutical liquid formulations |
| 01/18/2001 | WO2001003693A1 Pharmaceutical composition containing fenofibrate and preparation method |
| 01/18/2001 | WO2001003686A2 Inhibitors of staphylococcus sara protein and their use in treating staphylococcal infections |
| 01/18/2001 | WO2001003685A2 Novel prodrugs for antimicrobial amidines |
| 01/18/2001 | WO2001003677A1 Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same |
| 01/18/2001 | WO2001003676A1 Improvements in and relating to delivery capsules |
| 01/18/2001 | WO2001003673A1 Dry powder compositions |
| 01/18/2001 | WO2001003672A1 Method for making granules with masked taste and instant release of the active particle |
| 01/18/2001 | WO2001003670A1 Method for controlled production of ultrafine microparticles and nanoparticles |
| 01/18/2001 | WO2001003669A2 Delivery of liposomal-encapsulated antioxidants and applications thereof |
| 01/18/2001 | WO2001003668A1 Pulmonary delivery of liposome-encapsulated cannabinoids |
| 01/18/2001 | WO2001003667A1 Delivery system for biological material |
| 01/18/2001 | WO2001003656A1 Antimicrobial artificial nail composition and methods for preparing and using same |
| 01/18/2001 | WO2001003650A2 Preservatives for perishable preparations, in particular for cosmetic and pharmaceutical preparations |